Ultrafine particles in airways during COVID-19 lockdown

E. Fireman Klein (HAIFA, Israel), Y. Elimelech (HAIFA, Israel), L. Majdoub (HAIFA, Israel), Y. Adir (HAIFA, Israel), M. Shteinberg (HAIFA, Israel)

Source: Virtual Congress 2021 – Environment and respiratory health
Session: Environment and respiratory health
Session type: Oral Presentation
Number: 104

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Fireman Klein (HAIFA, Israel), Y. Elimelech (HAIFA, Israel), L. Majdoub (HAIFA, Israel), Y. Adir (HAIFA, Israel), M. Shteinberg (HAIFA, Israel). Ultrafine particles in airways during COVID-19 lockdown. 104

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Retention of ultrafine particles in the human lung
Source: Eur Respir J 2004; 24: Suppl. 48, 236s
Year: 2004

Trajectory of inhaled cadmium ultrafine particles in smokers.
Source: Virtual Congress 2021 – Chronic airway, interstitial, pleural and neoplastic diseases
Year: 2021

Extrapulmonary effects of inhaled ultrafine carbon particles in mice
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008

Deposition of ultrafine (nano)particles in the human lung and the mechanisms behing the health effects
Source: International Congress 2014 – Nanomaterials and respiratory health
Year: 2014

Negligible clearance of ultrafine particles retained in healthy and affected human lungs
Source: Eur Respir J 2006; 28: 286-290
Year: 2006

Mechanism of lung injury caused by PM10 and ultrafine particles with special reference to COPD
Source: Eur Respir J 2003; 21: 47S-51S
Year: 2003

Respiratory effects of vehicle exhaust ultrafine particles versus secondary ultrafine particles in ambient air
Source: International Congress 2016 – Population-based insights into occupational and environmental lung disease
Year: 2016

Ultrafine carbon particles impair the phagocytic function of human alveolar macrophages
Source: Eur Respir J 2002; 20: Suppl. 38, 21s
Year: 2002

The generation of monodisperse pharmacological aerosols using a spinning-top aerosol generator (STAG)
Source: Eur Respir J 2005; 26: Suppl. 49, 125s
Year: 2005

Inhalation of nano-scaled titianium dioxide particles aggravates airway inflammation in allergen-challenged mice
Source: Annual Congress 2011 - Environmental exposure and disease mechanisms
Year: 2011

Development of an in vitro pulmonary translocation system for ultrafine particles
Source: Eur Respir J 2005; 26: Suppl. 49, 387s
Year: 2005

Welding fumes change the lipid composition of particles in exhaled air.
Source: International Congress 2018 – Occupational and environmental lung diseases: mechanisms, biomarkers and causation
Year: 2018

Bioreactivity and fate of nanoparticles deposited at the pulmonary epithelial interface: focus on traffic-derived particulate matter
Source: International Congress 2016 – Traffic air pollution in urban areas
Year: 2016

Measuring peripheral lung dimensions with the deposition of aerosol nanoparticles
Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases
Year: 2021

No evidence electric charge increases inhaled ultrafine particle deposition in human lungs
Source: Virtual Congress 2020 – Occupational and environmental causes of respiratory disease
Year: 2020

Fate of inhaled ultrafine carbon particles after one week; human exposure using a novel aerosol with 111indium
Source: Annual Congress 2012 - Air pollution: from the particles in town to the pollutants in the countryside
Year: 2012

Airway inflammation in iron ore miners exposed to dust and diesel exhaust
Source: Eur Respir J 2006; 27: 714-719
Year: 2006

Exposure to ultrafine particles and respiratory hospitalisations in five European cities
Source: Eur Respir J 2016; 48: 674-682
Year: 2016